《LANCET,2月10日,The first 2019 novel coronavirus case in Nepal》

  • 来源专题:COVID-19科研动态监测
  • 编译者: xuwenwhlib
  • 发布时间:2020-02-11
  • The first 2019 novel coronavirus case in Nepal

    Anup Bastola,Ranjit Sah,Alfonso J Rodriguez-Morales,Bibek Kumar Lal,Runa Jha,Hemant Chanda Ojha

    Published:February 10, 2020

    DOI:https://doi.org/10.1016/S1473-3099(20)30067-0

    In January, 2020, the outbreak of the 2019 novel coronavirus (2019-nCoV) in China spread progressively to other countries,1, 2 with WHO declaring it a Public Health Emergency of International Concern.3 Among the affected countries beyond China (where 12?307 cases and 259 deaths were reported as of Feb 1, 2020) are others in Asia, including Nepal.4

    On Jan 13, 2020, a 32-year-old man, a Nepalese student at Wuhan University of Technology, Wuhan, China, with no history of comorbidities, returned to Nepal. He presented at the outpatient department of Sukraraj Tropical and Infectious Disease Hospital, Kathmandu, with a cough. He had become ill on Jan 3, 6 days before he flew to Nepal. He indicated no exposure to the so-called wet market in Wuhan. Throat swabs obtained from the patient tested positive for 2019-nCoV on real-time RT-PCR assays at the WHO laboratory in Hong Kong. On admission to hospital in Kathmandu, his temperature was 37·2°C (99°F), with throat congestion, but with no other relevant signs or symptoms. He was isolated and treated with broad-spectrum antibiotics and supportive therapies. After 6 h, he complained of mild breathing difficulty and had decreased oxygen saturation (SpO2 87% on room air). Chest radiographs obtained on admission showed an infiltrate in the upper lobe of the left lung (figure). On Jan 14, his temperature rose to 38·9°C (102°F) and the next day he had breathing difficulties while in the supine position, with crepitations in the right lower lung field. His fever was no longer present on Jan 16, and his clinical condition improved. He was discharged the next day and instructed to self-quarantine at home. Laboratory tests showed no abnormalities. Real-time RT-PCR assays for influenza A and B viruses, and NS1 antigen rapid tests for dengue viruses, scrub typhus, and Brucella spp were negative. Follow-up assessments on Jan 29 and Jan 31 gave an RT-PCR negative throat swab for 2019-nCoV. Informed consent was obtained from the patient to be included in this Correspondence.

  • 原文来源:https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30067-0/fulltext
相关报告
  • 《Lancet Infectious Diseases,2月10日,The first 2019 novel coronavirus case in Nepal》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangzx
    • 发布时间:2020-02-11
    • CORRESPONDENCE|ONLINE FIRST The first 2019 novel coronavirus case in Nepal Anup Bastola, Ranjit Sah, Alfonso J Rodriguez-Morales, Bibek Kumar Lal, Runa Jha, Hemant Chanda Ojha, Bikesh Shrestha, Daniel K W Chu, Leo L M Poon, Anthony Costello, Kouichi Morita, Basu Dev Pandey The Lancet Infectious Diseases Published: February 10, 2020 On Jan 13, 2020, a 32-year-old man, a Nepalese student at Wuhan University of Technology, Wuhan, China, with no history of comorbidities, returned to Nepal. He presented at the outpatient department of Sukraraj Tropical and Infectious Disease Hospital, Kathmandu, with a cough. He had become ill on Jan 3, 6 days before he flew to Nepal. He indicated no exposure to the so-called wet market in Wuhan. Throat swabs obtained from the patient tested positive for 2019-nCoV on real-time RT-PCR assays at the WHO laboratory in Hong Kong. ,,,,,
  • 《LANCET,2月15日,Africa prepares for coronavirus》

    • 来源专题:COVID-19科研动态监测
    • 编译者:dingxq
    • 发布时间:2020-02-16
    • Africa prepares for coronavirus Munyaradzi Makoni DOI:https://doi.org/10.1016/S0140-6736(20)30355-X With cases of novel coronavirus spreading worldwide, governments and institutions are getting ready for the first cases in Africa. Munyaradzi Makoni reports from Cape Town. On Jan 30, WHO Director-General Dr Tedros Adhanom Ghebreyesus declared that the novel coronavirus (2019-nCoV) epidemic, centred in China, was a public health emergency of international concern. A large part of WHO's reasoning was that “a global coordinated effort is needed to enhance preparedness in other regions of the world”. As cases continue to rise, and spread worldwide, governments and institutions are taking action to prepare for the first patients in Africa. “The risk and likelihood of getting an outbreak is very, very high”, said Ambrose Talisuna, the WHO Africa team lead for emergency preparedness. As of Feb 11, Africa does not have any confirmed cases, but suspected patients have been quarantined in Ethiopia, Kenya, Côte d'Ivoire, and Botswana. Dr Tedros announced on Feb 5 that a US$675 million preparedness and response plan covering February to April, 2020, had been initiated by the international community for China and globally to protect states with weaker health systems. WHO has prioritised support for 13 countries on the basis of their close transport links with China: Algeria, Angola, Côte d'Ivoire, the Democratic Republic of the Congo, Ethiopia, Ghana, Kenya, Mauritius, Nigeria, South Africa, Tanzania, Uganda, and Zambia. “We all know how fragile health systems [are] in the African continent, they are already overwhelmed by many outbreaks. For us, it is critical to detect coronavirus earlier [so] that we can prevent spreading within communities that can trigger a number of cases that can overwhelm the treatment capacity”, said Michel Yao, WHO Africa programme manager for emergency operations. The strategy is to prepare country technical guidance, advising ministries of health on how to limit human-to-human transmission, ensure countries have capacity to isolate and provide appropriate treatment to affected people, Yao said. The Africa Centres for Disease Control and Prevention (Africa CDC) established the Africa Task Force for Novel Coronavirus on Feb 3. It is working with WHO on surveillance, including screening at points of entry, infection prevention and control in health-care facilities, clinical management of people with severe 2019-nCoV infection, laboratory diagnosis, and risk communication and community engagement. The Director of Africa CDC, John Nkengasong, outlined the threat to Africa posed by 2019-nCoV. “This disease is a serious threat to the social dynamics, economic growth, and security of Africa”, said Nkengasong. “If we do not detect and contain disease outbreaks early, we cannot achieve our developmental goals.” Yao said WHO is working with various partners to ensure that there is a proper screening process at the main points of entry, that suspected cases are isolated, and that protective equipment is provided. The guidance requires that alerts be raised on suspected cases. Health workers have been taught how to behave in front of people with suspected or confirmed infection. In-country incidence management teams have also been set up. Even in countries where there is instability, such as South Sudan, coordination mechanisms have been worked out to reach health workers and patients. Thanks to Ebola, Yao said, most of the countries have isolation infrastructure. “We are pushing for the continent to be very vigilant”, he added. Hilde De Clerck, emerging infections adviser with Médecins Sans Frontières, made the point that some health systems are already well organised and have able leadership but will have to adapt to respond successfully to an outbreak. South Africa's National Institute of Communicable Diseases and Senegal's Institut Pasteur were initially the only referral laboratories on the continent, and so were responsible for testing samples from other African countries. By Feb 4, more countries—Ghana, Madagascar, Sierra Leone, and Nigeria—were also able to do testing themselves. As of Feb 10, WHO said that 11 countries were capable of testing for 2019-nCoV, and reagents should be delivered to other countries this week. Africa's preparedness efforts have been boosted with $25 million from the Bill & Melinda Gates Foundation, with some of it going towards training. 15 experts from the African Union received training on laboratory diagnosis for 2019-nCoV in Dakar, Senegal, on Feb 6–8. WHO is also supporting training in Ethiopia and other countries on isolation and treatment and care of infected patients.